| Zilovertamab vedotin | MK-2140; VLS-101 | Phase 3 Clinical | Velosbio Inc | Breast Neoplasms; Burkitt Lymphoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Neoplasms; Neuroblastoma; Ovarian Neoplasms; Pancreatic Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Richter's Syndrome; Sarcoma, Ewing; Stomach Neoplasms; Triple Negative Breast Neoplasms; Waldenstrom Macroglobulinemia | Details |
| B-013 | B-013; B013 | Phase 3 Clinical | Shanghai Crosslink Pharmaceutical R & D Co Ltd | Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Triple Negative Breast Neoplasms | Details |
| Zilovertamab | UC-961 | Phase 2 Clinical | University Of California San Diego | Breast Neoplasms; Immune System Diseases; Immunoproliferative Disorders; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphatic Diseases; Lymphoma; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Prostatic Neoplasms, Castration-Resistant | Details |
| EMB-07 | EMB-07 | Phase 2 Clinical | Shanghai Epimab Biotherapeutics, Inc | Adenocarcinoma of Lung; Colorectal Neoplasms; Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Neoplasms | Details |
| EB-DT-CAR-NK | EB-DT-CAR-NK | Phase 2 Clinical | Beijing Biotech | Breast Neoplasms; Triple Negative Breast Neoplasms | Details |
| NVG-222 | NVG-222 | Phase 2 Clinical | NovalGen Ltd | Hematologic Neoplasms; Neoplasms | Details |
| HDM-2005 | HDM2005; HDM-2005 | Phase 2 Clinical | Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | Hematologic Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Neoplasms; Solid tumours | Details |
| Nebratamig | GNC-035 | Phase 2 Clinical | Sichuan Baili Pharmaceutical Co Ltd | Breast Neoplasms; Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Metastatic breast cancer; Solid tumours | Details |
| HG-030 | HG-030 | Phase 1 Clinical | Hitgen Inc | | Details |
| anti-ROR1 CAR T-cell therapy (Fred Hutchinson Cancer Research Center/NCI) | | Phase 1 Clinical | National Cancer Institute | | Details |
| PB-004 | PB004; PBA-0405; PB004 PureBIKE; PB-004 | Phase 1 Clinical | Pure Biologics SA | Sarcoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms | Details |
| PRGN-3007 | PRGN-3007 | Phase 1 Clinical | Precigen Inc | Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Solid tumours; Triple Negative Breast Neoplasms | Details |
| RD-14 | RD-14; RD-14-01; CTE001; RD14-01 | Phase 1 Clinical | Nanjing Bioheng Biotech Co Ltd | Breast Neoplasms; Lymphoma, Non-Hodgkin; Ovarian Neoplasms | Details |
| NEOK-001 | NEOK001; NEOK-001; ABL206; ABL-206 | Phase 1 Clinical | Abl Bio Inc | | Details |
| BR-111 | BR-111 | Phase 1 Clinical | Zhejiang BioRay Biopharmaceuticals Co Ltd | | Details |
| SYS-6005 | RB-164; RB164; SYS6005Y; SYS-6005 | Phase 1 Clinical | CSPC Pharmaceutical Group Ltd | Hematologic Neoplasms; Leukemia, B-Cell; Lymphoma, B-Cell; Neoplasms; Solid tumours | Details |
| TQB-2101 | TQB2101; TQB-2101 | Phase 1 Clinical | Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group | Breast Neoplasms; Colorectal Neoplasms; Hematologic Neoplasms; Lung Neoplasms; Neoplasms | Details |
| ZPC-21 | ZPC-21; IM-1021 | Phase 1 Clinical | Zentalis Pharmaceuticals Inc | Hematologic Neoplasms; Neoplasms; Solid tumours | Details |
| BR-111A | BR-111A; BR111A; BR-111-A | Phase 1 Clinical | Zhejiang BioRay Biopharmaceuticals Co Ltd | Hematologic Diseases; Neoplasms; Solid tumours | Details |
| LYL-797 | LYL-797 | Phase 1 Clinical | Lyell Immunopharma Inc | Carcinoma, Non-Small-Cell Lung; Solid tumours; Triple Negative Breast Neoplasms | Details |
| NVG-111 | NVG-111 | Phase 1 Clinical | NovalGen Ltd | Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Melanoma | Details |
| LCB-71 | CS-5001; LCB-71; ABL-202; ROR1-pPBD | Phase 1 Clinical | Abl Bio Inc, Legochem Biosciences Inc | Hematologic Neoplasms; Lymphoma; Lymphoma, B-Cell; Solid tumours | Details |
| SIM-201 | SIM-201; SIM-0201 | Phase 1 Clinical | Jiangsu Simcere Pharmaceutical Co Ltd | | Details |
